1.The study of influence on cyclin and cyclin-dependent kinase inhibitor of Kasumi-1 cell treated with VPA
Lei ZHAO ; Zhihua ZHANG ; Cuimin ZHU ; Wenliang TIAN ; Changlai HAO
Journal of Leukemia & Lymphoma 2009;18(1):5-8
Objective To explore the influence on cyclin and cyclin-dependent kinase inhibitor of cell cycle of Kasumi-1 cell-derived from t(8;21)/AML treated with histone deacetylase(HDAC)inhibitor valproic acid(VPA).Methods RT-PCR assay was applied to detect mRNA expression of regulation factor of cell cycle of Kasumi-1 cell with VPA at different concentration and different time. Results VPA could down-regulate mRNA expression of cyclinD1,cyclinE1 and cyclinB1,and up-regulate mRNA expression of p21 WAF1/CIP1 with no obvious variation of mRNA level of p27KIP1. Condusion VPA could regulate cell cycle through the regulation of cyclins and cyclin-dependent kinase,arresting Kasumi-1 cell at G0/G1 phase.
2.Diagnosis and treatment of heterotopic pancreas at the angular notch of stomach misdiagnosed as gastric stromal tumor
Minghui WANG ; Zihui LIU ; Guanghai WU ; Zhuxin WANG ; Dawei HU ; Changlai HAO
Chinese Journal of Digestive Surgery 2015;14(3):248-249
Heterotopic pancreas is usually defined as a presence of pancreatic tissue without any anatomical or vascular continuity,and is one of the congenital and rare diseases.The clinical manifestations are easily confused with other gastrointestinal diseases,and conventional endoscopic examination cannot provide a clear preoperative diagnosis,therefore heterotopic pancreas is often misdiagnosed.It is very important to distinguish heterotopic pancreas and other digestive diseases.In this article,the clinical characteristics,differential diagnosis and treatment method of one patient with heterotopic pancreas who was admitted to the Affiliated Hospital of Chengde Medical College in March 2014 were analyzed.
3.Clinical value of transthyretin from patients with early rheumatoid arthritis
Lei ZHAO ; Zhihua ZHANG ; Chunqiang BAI ; Fengyun JIANG ; Zhiqiang LIANG ; Xueyan WANG ; Changlai HAO
The Journal of Practical Medicine 2016;32(14):2337-2339
Objective To investigate the clinical value of transthyretin (TTR) from patients with early rheumatoid arthritis (ERA). Methods 58 patients with ERA , 34 patients with later RA (LRA) and 34 healthy control (HC) were included in the research. TTR was analyzed by ELISA, whose variance was analyzed. TTR density, disease activity score28 (DAS28) score and rheumatoid factor (RF) were tested, and their correlation with TTR was analyzed. Results Serum level of TTR with ERA significantly increased compared with that with LRA and HC (P < 0.05), no statistical significance with LRA group and HC. TTR level was no correlation with the number of swelling and tender joints, disease activity score 28, RF, ESR, CRP, anti-cyclic citrylinated peptide antibody and anti-keratin antibodies, hemoglobin, thrombocyte and albumin. Conclusion Serum level of TTR significantly increased with ERA patients, contributing to early diagnosis for RA.
4.Complications and conversions in myeloproliferative disorders: an analysis of 356 cases.
Yi WANG ; Anlan ZUO ; Yinghui LIU ; Bingcheng LIU ; Changlai HAO ; Lihong WANG ; Xueli ZHOU ; Linsheng QIAN
Chinese Journal of Hematology 2002;23(6):314-317
OBJECTIVETo investigate the complications and conversions in myeloproliferative disorders (MPD).
METHODSThree hundred and fifty six patients with MPD were reviewed, including 78 with etiologic thrombocythemia (ET), 93 with primary myelofibrosis (MF), 185 with polythythemia vera (PV). The clinical observation, follow-up, analysis with SPSS statistic software were performed.
RESULTSOut of the 356 cases, 101 (28.5%) developed thromboembolic events, 81 (22.8%) hemorrhage, 60 (16.9%) hypertension, 20 (5.6%) coronary heart disease, 3 (0.8%) hemolysis and 1 (0.3%) gastrointestinal ulcer, 2 (0.6%) calculus and 1 (0.3%) bone marrow necrosis. Twenty four patients (6.7%) developed MF (9 in ET, 15 in PV), 2 (0.6%) erythrocytosis (1 in ET, 1 in MF), 3 (0.8%) thrombocythemia (all in PV), 5 (1.4%) acute leukemia (2 in ET, 3 in MF) and 1 (0.3%) multiple myeloma (in ET). Eleven cases (3.1%) died, 5 (1.4%) from acute leukemia, 2 (0.6%) fatal hemorrhages, 1 (0.3%) each myocardial infarction and infectious shock, 2 (0.6%) unknown causes.
CONCLUSIONEmbolism and bleeding were the main complications in MPD. Conversions among ET, MF and PV hematological malignancies could occur.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Female ; Humans ; Male ; Middle Aged ; Myeloproliferative Disorders ; complications ; mortality
5.Effects of different gauze folding patterns on local hemostasis after peripherally inserted central catheters
Lishuang ZHAO ; Shaomei WANG ; Lei ZHAO ; Zhihua ZHANG ; Changlai HAO
Chinese Journal of Clinical Nutrition 2018;26(4):254-255
Objective To observe the effects of two different gauze folding patterns used in local hemostasis after peripherally inserted central catheters (PICC).Methods A total of 152 patients were selected and divided into two groups according to PICC date sequence as control group of 72 patients using 2.0 cm× 2.0 cm little gauze to oppress the puncture point and observation group of 80 patients using 1.0 cm× 1.5 cm gauze ball made by ourselves to oppress the puncture point.The oozing of the puncture point was observed in patients of the two groups.Results The hemostasis was better in the observation group than in the control group (x2=15.88,P<0.01).No limb swelling happened to the patients in the observation group (x2=58.064,P<0.01).There was statistically significant difference in hemostatic effect between the two groups.Conclusion The sterile gauze ball made by ourselves has a good effect on local hemostasis through oppressing the puncture point without any impact on blood circulation of limbs.
6. Gene identification in a family of hereditary hemorrhagic telangiectasia
Lihong WANG ; Zhihua ZHANG ; Cuihong GU ; Li LIN ; Taoran WANG ; Changlai HAO
Chinese Journal of Hematology 2018;39(6):476-479
Objective:
To study the mutation of ENG, ACVRL1, and SMAD4 genes in one of a family of hereditary hemorrhagic telangiectasia (HHT) and explore its molecular pathogenesis.
Methods:
A family spectrum of a patient with a clinical diagnosis of HHT was surveyed. Peripheral blood samples from proband and their eldest were collected, and ENG, ACVRL1 and SMAD4 gene analysis was performed by chip capture high-throughput sequencing. The mutation detected was verified by Sanger.
Results:
9 of the 71 family members were diagnosed with HHT with the main manifestation of recurrent nasal bleeding. Genetic analysis showed that the proband and the eldest son of ENG gene exon 9 frameshift mutation: c.1502-1503insGG (p.Gly501GlyfsX18) , and mutations in ACVRL1 and SMAD4 genes were not detected.
Conclusion
The frameshift mutation c.1502-1503insGG (p.Gly501GlyfsX18) of the ENG gene is the genetic basis for the pathogenesis of this HHT family.
7.Determination of ETO interaction domain within nuclear receptor co-repressor.
Min WANG ; Changlai HAO ; Kejing TANG ; Haiyan XING ; Zheng TIAN ; Yi ZHANG ; Jianxiang WANG
Chinese Journal of Hematology 2002;23(12):621-623
OBJECTIVETo determine the ETO-interaction domain of nuclear receptor co-repressor (N-CoR) for abolishing the biological function of AML1-ETO.
METHODSTen different regions of N-CoR (N-CoRYs) were generated by means of polymerase chain reaction (PCR), and cloned into yeast expression plasmid pGADGL to construct pGADGL/N-CoRYs. The yeast two-hybrid technique and X-gal staining were used to determine the binding between the 10 different regions of N-CoR and ETO.
RESULTSIt was shown that the co-existence of 988-1,126 and 1,551-1,803 amino acid residues of N-CoRY was the ETO-interaction domains required for the binding with ETO.
CONCLUSIONTwo domains of N-CoR that interact with two zinc fingers of ETO, and keep stable binding between the two proteins were identified.
Binding Sites ; genetics ; Humans ; Nuclear Proteins ; chemistry ; genetics ; metabolism ; Nuclear Receptor Co-Repressor 1 ; Plasmids ; genetics ; Protein Binding ; Proto-Oncogene Proteins ; genetics ; metabolism ; RUNX1 Translocation Partner 1 Protein ; Recombinant Fusion Proteins ; genetics ; metabolism ; Repressor Proteins ; chemistry ; genetics ; metabolism ; Transcription Factors ; genetics ; metabolism ; Transfection ; Two-Hybrid System Techniques